NCT01187212 2020-01-07
Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE
Asan Medical Center
Phase 2 Completed
Clinical Trials
4 trialsNCT01158287 2014-12-31
Sorafenib. ICORG 06-41, V4
Cancer Trials Ireland
Phase 2 Completed
NCT00253370 2014-11-24
Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00595985 2009-07-07
Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
Fudan University
Phase 2 Terminated